8-K Announcements
6Material company update
Jul 21, 2026·SEC
Material company update
Jun 24, 2026·SEC
Material company update
Apr 8, 2026·SEC
Vicarious Surgical faces a critical liquidity inflection point as it continues to operate without revenue while sustaining quarterly R&D expenditures of $5.0 million.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Benchmark RBOT against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Vicarious Surgical Inc. (RBOT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.00 | $9.72K | -0.00 | — | — | -333.19% | — | |
| $452.80 | $159.96B | 53.84 | 20.51% | 25.54% | 16.91% | — | |
| $6.42 | $557.35M | -4.85 | -3.73% | -21.05% | -13.8% | — | |
| $4.03 | $261.44M | -4.73 | 1.59% | -27.44% | -75.93% | — | |
| $325.87 | $124.93B | 34.60 | 11.16% | 13.78% | 15.61% | 1.03% | |
| $101.80 | $130.7B | 25.01 | 8.43% | 13.93% | 10.51% | 2.78% |
Vicarious Surgical Inc. (RBOT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Vicarious Surgical Inc. (RBOT) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 21, 2026·SEC
Jun 24, 2026·SEC
Apr 8, 2026·SEC
Get notified when RBOT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Vicarious Surgical Inc. (RBOT) stock FAQ — growth, dividends, profitability & financials explained
No. Vicarious Surgical Inc. (RBOT) reported a net loss of $42.1M over the trailing twelve months.
Vicarious Surgical Inc. (RBOT) had a return on equity (ROE) of -333.2% over the trailing twelve months. A negative ROE means the company lost money over the period.
Vicarious Surgical Inc. (RBOT) had negative free cash flow of $39.7M over the trailing twelve months.